talazoparib
Talzenna with Enzalutamide Approved for HRR Gene-mutated mCRPC
The FDA approved talazoparib (Talzenna, Pfizer) with enzalutamide for homologous recombination repair (HRR) ...
JUNE 26, 2023
Adding Talazoparib to Enzalutamide in mCRPC Improves Outcomes
In patients with metastatic, castration-resistant prostate cancer, adding the PARP inhibitor talazoparib (Talzenna, ...
MARCH 10, 2023
FDA Approves Talzenna for gBRCAm HER2– Breast Ca
The FDA approved Talzenna, a poly(adenosine diphosphate–ribose) polymerase inhibitor, for patients with ...
OCTOBER 18, 2018
Load more